65
Participants
Start Date
October 31, 2009
Primary Completion Date
September 30, 2010
Study Completion Date
September 30, 2010
nicotine
Oral capsule self administered in escalating doses from 1 mg to 6 mg, 4 times a day. Each dose is is taken for two weeks, except the highest dose, which is taken for 4 weeks. At the end of 10 weeks, the dose is tapered down over 9 days. Subject is continued on study through week 14.
placebo comparator
oral capsules containing only excipient will be self-administered with the same regimen as the active drug, 4 times a day, approximately every 6 hours for 10 weeks and nine days. Study is continued through week 14.
108-14 72nd Ave, Second floor, Forest Hills
David L. Kreitzman, M.D., P.C., Commack
Parkinson's Disease and Movement Center, Penn Comprehensive Neuroscience Center, Philadelphia
Duke University Medical Center, Department of Neurology, Durham
Parkinson's Disease & Movement Disorders Ctr of Boca Raton, Boca Raton
Collier Neurologic Specialists, LLC, Naples
Strurers Parkinson's Center, Golden Valley
The Movement Disordedr Clinic of Oklahoma, Tusla
Colorado Neurological Institute, Englewood
Barrow Neurology Clinics at St. Joseph's Hospital and Medical Center, Phoenix
Keck/USC School of Medicine -Department of Neurology, Los Angelis
Pacific Neuroscience Medical Group, Oxnard
Lead Sponsor
Neuraltus Pharmaceuticals, Inc.
INDUSTRY